BLOG

Sunday, July 19, 2020

Pharma firms likely to report mixed performance in Q1 on Covid-19, lockdown

Companies with higher exports are likely to benefit due to the rupee depreciation against the US dollar.

from Companies https://ift.tt/3heC4F8
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...